Around the World

The debate around cannabis legalisation in the United Kingdom has been gaining momentum in recent years – fuelled by calls from the London Drugs Commission to decriminalise small amounts. Yet Prime Minister Keir Starmer has now drawn a clear line: under his Labour government, there will be no legalisation of recreational cannabis. Starmer draws a […]

Europe is increasingly moving into the spotlight of international cannabis investors. Just a few weeks after the acquisition of Remexian Pharma by High Tide in Germany, another deal is making headlines: Casa Verde Capital, the venture fund co-founded by Snoop Dogg, has invested £4.5 million into the UK medical cannabis clinic Mamedica. Founded in 2022,

What You Need to Know About the World’s Next Cannabis Superpower Executive Summary: With Anutin Charnvirakul – Thailand’s “Cannabis King” – now serving as Prime Minister, the Southeast Asian nation is positioned to become one of the world’s largest cannabis markets. Our complete analysis reveals why Thailand could challenge established markets like Canada and Germany

Thailand’s healthcare technology landscape is rapidly evolving as new cannabis regulations reshape opportunities for startups and investors. The Department of Thai Traditional and Alternative Medicine (DTAM), in partnership with the SME Council and leading health tech firms, is pioneering a digital transformation with a centralized platform for medical cannabis control. Key Regulatory Changes DTAM has rolled out

A new bill promises broader access and less bureaucracy for patients. But opposition from doctors, insurers, and police casts a long shadow. Last Tuesday, the Israeli Knesset’s Public Committee approved a long-debated bill to reform the country’s medical cannabis framework. Initially introduced by MK Sharren Haskel and now revived by MK Moshe Passal, the bill

Malta made headlines in 2021 when it became the first EU country to legalize the personal use and cultivation of cannabis. Yet despite this progressive image, the reality on the ground remains complex. Recent legislation introducing €250 fines for cannabis odour—yes, smell—reveals a deeper cultural tension and regulatory inconsistency. But for cannabis startups, this isn’t

Today, Italy’s Administrative Court (TAR) dismissed the appeal filed by national hemp associations against the Ministry of Health’s decree classifying oral-use CBD preparations as narcotic substances. The ruling marks another serious setback for the Italian hemp and CBD sector—and may significantly impact the country’s future in the European cannabinoid market. A Dangerous Legal Precedent By

In a significant step forward for cannabis policy in Latin America, a group of progressive Chilean lawmakers has introduced a bill to regulate adult use of cannabis. The “Regulación por la paz” parliamentary group, led by Deputy Ana María Gazmuri, presented the initiative in the Chilean Congress, aiming to create a legal and responsible framework

As of April 1, 2025, all general practitioners in Czechia are authorized to prescribe medical cannabis. This development significantly expands patient access and reshapes the country’s position within the European cannabis landscape. It is also a policy signal worth close attention from investors, healthtech companies, and international producers aiming to enter the Czech or broader

After years of delays, France is now taking decisive steps toward comprehensive regulation of medical cannabis. Two ordinances specifying cannabis-based medicinal products and their production have been NOT SUBMITTED yet (I hope they will be!) to the European Commission (EC) for review. This development signals a potential market opening, particularly interesting for startups and investors